Jason M. Ridlon
- Hepatology top 0.5%
- Liver Disease and Transplantation 7
- Gastroenterology top 0.5%
- Biological Psychiatry top 1%
- Molecular Biology top 1%
- Gut microbiota and health 30
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 18
-
- Diet and metabolism studies 12
-
- Liver Disease Diagnosis and Treatment 10
-
- Pharmacogenetics and Drug Metabolism 8
-
- Hormonal Regulation and Hypertension 8
-
- Clostridium difficile and Clostridium perfringens research 7
- Co-authors
- Phillip B. HylemonJasmohan S. BajajSpencer HarrisPatrick M. GillevetDouglas M. HeumanShiva BhowmikMasoumeh SikaroodiH. Rex Gaskins
- Partner nations
- United StatesBrazilUnited Kingdom
In The Last Decade
Jason M. Ridlon
65 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Hepatology 1.0k
- Gastroenterology 655
- Biological Psychiatry 262
- Molecular Biology 5.2k
- Oncology 2.0k
Countries citing papers authored by Jason M. Ridlon
This map shows the geographic impact of Jason M. Ridlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason M. Ridlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason M. Ridlon more than expected).
Fields of papers citing papers by Jason M. Ridlon
This network shows the impact of papers produced by Jason M. Ridlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason M. Ridlon. The network helps show where Jason M. Ridlon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jason M. Ridlon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | Another renaissance for bile acid gastrointestinal microbiologybreakdown → | 2024 | 76 |
| 6 | 2023 | 4 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 70 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 46 | |
| 12 | 2021 | 62 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 17 | |
| 15 | 2020 | 47 | |
| 16 | Metabolism of oxo-bile acids and characterization of recombinant 12α-hydroxysteroid dehydrogenases from bile acid 7α-dehydroxylating human gut bacteria | 2018 | 12 |
| 17 | Consequences of bile salt biotransformations by intestinal bacteriabreakdown → | 2016 | 770 |
| 18 | 2013 | 227 | |
| 19 | 2013 | 322 | |
| 20 | Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. | 2005 | 209 |
About Jason M. Ridlon
Jason M. Ridlon is a scholar working on Pharmacology, Hepatology and Clinical Biochemistry, having authored 66 papers that have together received 8.3k indexed citations. Recurring topics across this work include Gut microbiota and health (30 papers), Drug Transport and Resistance Mechanisms (18 papers), Diet and metabolism studies (12 papers), Liver Disease Diagnosis and Treatment (10 papers), Pharmacogenetics and Drug Metabolism (8 papers), Hormonal Regulation and Hypertension (8 papers), Liver Disease and Transplantation (7 papers) and Clostridium difficile and Clostridium perfringens research (7 papers). The work is most often cited by research in Hepatology (1.0k citations), Gastroenterology (655 citations) and Biological Psychiatry (262 citations). Jason M. Ridlon has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Phillip B. Hylemon, Jasmohan S. Bajaj, Spencer Harris, Patrick M. Gillevet, Douglas M. Heuman, Shiva Bhowmik, Masoumeh Sikaroodi, H. Rex Gaskins, Patricia G. Wolf and Melanie B. White.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.